News Detail
Mumbai, 19 Dec 2024: Cipla has introduced CipAir, a mobile application designed to enable timely first-line asthma screening in India. Clinically validated through a multi-centre study, the app aims to empower individuals by helping them identify the likelihood of asthma, facilit......
View Details
Source : Express Pharma
Cipla introduces AI-powered mobile application for asthma screening in India
Related News
- Sirsa: About 83 thousand 545 pills recovered from a house, accused arrested (16-01-2025)
- AI eBay algorithm blocks two million illegal medicine sales (16-01-2025)
- Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)
- Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)